446 related articles for article (PubMed ID: 26446169)
1. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
Sadanandam A; Wullschleger S; Lyssiotis CA; Grötzinger C; Barbi S; Bersani S; Körner J; Wafy I; Mafficini A; Lawlor RT; Simbolo M; Asara JM; Bläker H; Cantley LC; Wiedenmann B; Scarpa A; Hanahan D
Cancer Discov; 2015 Dec; 5(12):1296-313. PubMed ID: 26446169
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.
Capodanno Y; Chen Y; Schrader J; Tomosugi M; Sumi S; Yokoyama A; Hiraoka N; Ohki R
Neoplasia; 2021 Sep; 23(9):979-992. PubMed ID: 34352404
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
Albrecht I; Kopfstein L; Strittmatter K; Schomber T; Falkevall A; Hagberg CE; Lorentz P; Jeltsch M; Alitalo K; Eriksson U; Christofori G; Pietras K
PLoS One; 2010 Nov; 5(11):e14109. PubMed ID: 21124841
[TBL] [Abstract][Full Text] [Related]
4. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
[TBL] [Abstract][Full Text] [Related]
5. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
[TBL] [Abstract][Full Text] [Related]
6. Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors.
Yamauchi Y; Kodama Y; Shiokawa M; Kakiuchi N; Marui S; Kuwada T; Sogabe Y; Tomono T; Mima A; Morita T; Matsumori T; Ueda T; Tsuda M; Nishikawa Y; Kuriyama K; Sakuma Y; Ota Y; Maruno T; Uza N; Masuda A; Tatsuoka H; Yabe D; Minamiguchi S; Masui T; Inagaki N; Uemoto S; Chiba T; Seno H
Cancer Res; 2020 Sep; 80(17):3620-3630. PubMed ID: 32591410
[TBL] [Abstract][Full Text] [Related]
7. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
[TBL] [Abstract][Full Text] [Related]
8. A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.
Michael IP; Saghafinia S; Hanahan D
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24184-24195. PubMed ID: 31704767
[TBL] [Abstract][Full Text] [Related]
9. Placenta-Specific 8 Is Overexpressed and Regulates Cell Proliferation in Low-Grade Human Pancreatic Neuroendocrine Tumors.
Tatura M; Schmidt H; Haijat M; Stark M; Rinke A; Diels R; Lawlor RT; Scarpa A; Schrader J; Hackert T; Schimmack S; Gress TM; Buchholz M
Neuroendocrinology; 2020; 110(1-2):23-34. PubMed ID: 31018208
[TBL] [Abstract][Full Text] [Related]
10. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
[TBL] [Abstract][Full Text] [Related]
11. Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
Young K; Lawlor RT; Ragulan C; Patil Y; Mafficini A; Bersani S; Antonello D; Mansfield D; Cingarlini S; Landoni L; Pea A; Luchini C; Piredda L; Kannan N; Nyamundanda G; Morganstein D; Chau I; Wiedenmann B; Milella M; Melcher A; Cunningham D; Starling N; Scarpa A; Sadanandam A
Gut; 2021 Oct; 70(10):1904-1913. PubMed ID: 32883872
[TBL] [Abstract][Full Text] [Related]
12. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Pea A; Hruban RH; Wood LD
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
Fielitz K; Althoff K; De Preter K; Nonnekens J; Ohli J; Elges S; Hartmann W; Klöppel G; Knösel T; Schulte M; Klein-Hitpass L; Beisser D; Reis H; Eyking A; Cario E; Schulte JH; Schramm A; Schüller U
Oncotarget; 2016 Nov; 7(46):74415-74426. PubMed ID: 27769070
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy.
Estrella JS; Ma LT; Milton DR; Yao JC; Wang H; Rashid A; Broaddus RR
Pancreas; 2014 Oct; 43(7):996-1002. PubMed ID: 25058880
[TBL] [Abstract][Full Text] [Related]
16. Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression.
Saghafinia S; Homicsko K; Di Domenico A; Wullschleger S; Perren A; Marinoni I; Ciriello G; Michael IP; Hanahan D
Cancer Discov; 2021 Oct; 11(10):2638-2657. PubMed ID: 33910926
[TBL] [Abstract][Full Text] [Related]
17. Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors: A Contemporary View.
Yu R
Pancreas; 2020 Jul; 49(6):733-736. PubMed ID: 32590616
[No Abstract] [Full Text] [Related]
18. Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
Yang KC; Kalloger SE; Aird JJ; Lee MKC; Rushton C; Mungall KL; Mungall AJ; Gao D; Chow C; Xu J; Karasinska JM; Colborne S; Jones SJM; Schrader J; Morin RD; Loree JM; Marra MA; Renouf DJ; Morin GB; Schaeffer DF; Gorski SM
Cell Rep; 2021 Oct; 37(2):109817. PubMed ID: 34644566
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides.
Takano Y; Kasai K; Takagishi Y; Kikumori T; Imai T; Murata Y; Hayashi Y
PLoS One; 2015; 10(7):e0133812. PubMed ID: 26192435
[TBL] [Abstract][Full Text] [Related]
20. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
